122 related articles for article (PubMed ID: 21328388)
1. Parvovirus 4 in French in-patients: a study of hemodialysis and lung transplant cohorts.
Touinssi M; Reynaud-Gaubert M; Gomez C; Thomas P; Dussol B; Berland Y; Basire A; Picard C; Cantaloube JF; de Micco P; Biagini P
J Med Virol; 2011 Apr; 83(4):717-20. PubMed ID: 21328388
[TBL] [Abstract][Full Text] [Related]
2. Persistence of novel human parvovirus PARV4 in liver tissue of adults.
Schneider B; Fryer JF; Reber U; Fischer HP; Tolba RH; Baylis SA; Eis-Hübinger AM
J Med Virol; 2008 Feb; 80(2):345-51. PubMed ID: 18098166
[TBL] [Abstract][Full Text] [Related]
3. Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens.
Botto S; Bergallo M; Sidoti F; Terlizzi ME; Astegiano S; Ponti R; Costa C; Cavallo R
New Microbiol; 2009 Apr; 32(2):189-92. PubMed ID: 19579698
[TBL] [Abstract][Full Text] [Related]
4. Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4.
Schneider B; Fryer JF; Oldenburg J; Brackmann HH; Baylis SA; Eis-Hübinger AM
Haemophilia; 2008 Sep; 14(5):978-86. PubMed ID: 18565125
[TBL] [Abstract][Full Text] [Related]
5. Human parvovirus PARV4 in clotting factor VIII concentrates.
Fryer JF; Hubbard AR; Baylis SA
Vox Sang; 2007 Nov; 93(4):341-7. PubMed ID: 18070279
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus PARV4 visualization and detection.
Tuke PW; Parry RP; Appleton H
J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
[TBL] [Abstract][Full Text] [Related]
8. First report of human parvovirus 4 detection in Iran.
Asiyabi S; Nejati A; Shoja Z; Shahmahmoodi S; Jalilvand S; Farahmand M; Gorzin AA; Najafi A; Haji Mollahoseini M; Marashi SM
J Med Virol; 2016 Aug; 88(8):1314-8. PubMed ID: 26812938
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus 4-like virus in blood products.
Szelei J; Liu K; Li Y; Fernandes S; Tijssen P
Emerg Infect Dis; 2010 Mar; 16(3):561-4. PubMed ID: 20202447
[TBL] [Abstract][Full Text] [Related]
10. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.
Grabarczyk P; Kalińska A; Kara M; Wieczorek R; Ejduk A; Sulkowska E; Gołębiowska-Staroszczyk S; Matysiak M; Baylis SA; Brojer E
J Med Virol; 2011 Jan; 83(1):142-9. PubMed ID: 21108352
[TBL] [Abstract][Full Text] [Related]
12. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.
Fryer JF; Delwart E; Hecht FM; Bernardin F; Jones MS; Shah N; Baylis SA
Transfusion; 2007 Jun; 47(6):1054-61. PubMed ID: 17524097
[TBL] [Abstract][Full Text] [Related]
13. Identification of human parvovirus 4 genotypes 1 and 2 in Chinese source plasma pools.
Jia J; Zhong Y; Zhang H; Yuan D; Ma L; Wang D; Zhang J; Ma Y
J Med Virol; 2021 Aug; 93(8):4780-4785. PubMed ID: 33200412
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
[TBL] [Abstract][Full Text] [Related]
15. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).
Corcioli F; Zakrzewska K; Fanci R; De Giorgi V; Innocenti M; Rotellini M; Di Lollo S; Azzi A
Virol J; 2010 Oct; 7():272. PubMed ID: 20950445
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
17. A two-step real-time PCR assay for quantitation and genotyping of human parvovirus 4.
Väisänen E; Lahtinen A; Eis-Hübinger AM; Lappalainen M; Hedman K; Söderlund-Venermo M
J Virol Methods; 2014 Jan; 195():106-11. PubMed ID: 24134943
[TBL] [Abstract][Full Text] [Related]
18. Novel parvovirus and related variant in human plasma.
Fryer JF; Kapoor A; Minor PD; Delwart E; Baylis SA
Emerg Infect Dis; 2006 Jan; 12(1):151-4. PubMed ID: 16494735
[TBL] [Abstract][Full Text] [Related]
19. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF
J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
[TBL] [Abstract][Full Text] [Related]
20. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
